Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Cetylpyridinium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 4/20 | 0.95 |
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.95 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.95 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.95 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.95 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.91 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CASP2 | P42575 | 1/20 | 1.00 |
| ▸ | RAD52 | P43351 | 3/20 | 0.95 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.95 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.95 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.95 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.95 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.95 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.95 |
| ▸ | ESR1 | P03372 | 1/20 | 0.95 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6300556 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL5084795 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL5092903 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL329731 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL1889303 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL3684318 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL996021 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL313837 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL329979 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 | |
| Cetylpyridinium SCHEMBL3232752 | 1.00 | KMT2A (1.00) | KMT2ASMN1; SMN2MEN1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 96191 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3836899-B1 | CHEMOTHERAPEUTIC PHARMACEUTICAL SUSPENSION FOR ORAL DOSAGE | ONCOSOL LTD (GB) | 2026-05-27 | — | — | EP | claimed |
| EP-4748368-A1 | COMPOSITION FOR ORAL HYGIENE PRODUCTS COMPRISING N-CETYLPYRIDINIUM CHLORIDE, A FLAVONOID AND A POLYMER | Curaden AG (CH) | 2026-05-27 | — | — | EP | claimed |
| CN-122075320-A | PH response microcapsule dental floss and preparation and use methods thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075547-A | Mouthwash, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-3897530-B1 | ANTIMICROBIAL COMPOSITIONS COMPRISING MODIFIED CLAY AND NONIONIC TRIBLOCK COPOLYMERS | UNILEVER IP HOLDINGS B V (NL) | 2026-05-20 | — | — | EP | claimed |
| CN-117550675-B | Preparation method of modified activated carbon capable of effectively removing phosphorus in glyphosate waste salt | 盐城工学院 | 2026-05-19 | — | — | CN | claimed |
| US-12629377-B2 | Lamotrigine oral liquid suspension and use thereof | ROWP IP HOLDING II LLC | 2026-05-19 | — | — | US | claimed |
| WO-2026101847-A1 | METHODS OF INFLUENZA VACCINATION AND COMPOSITIONS FOR THE SAME | BLUEWILLOW BIOLOGICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-121060472-B | Composite modified montmorillonite for rare metal separation | 江西理工大学 | 2026-05-15 | — | — | CN | claimed |
| US-4069384-A | CYCLIC ANHYDRIDE; QUATERNARY AMMONIUM SALTS OR HALOGEN ACID SALTS AS CATALYSTS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-01-17 | — | — | US | claimed |
| US-4042679-A | BIS-BIGUANIDOHEXANES, QUATERNARY AMMONIUM SALTS, POLYMERIC POLYPHOSPHONIC COMPOUND | COLGATE-PALMOLIVE COMPANY (US) | 1977-08-16 | — | — | US | claimed |
| US-4028270-A | Vinyl polymerization initiator and reducing agent | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1977-06-07 | — | — | US | claimed |
| US-4021537-A | ALKYL DIMETHYL BENZYL AMMONIUM HALIDE, ESTER OF BIS(TRI-N-BUTYLTIN)OXIDE | RESEARCH LAB PRODUCTS, INC. (US) | 1977-05-03 | — | — | US | claimed |
| US-4007258-A | Sustained release pesticidal composition | UNION CORPORATION (US) | 1977-02-08 | — | — | US | claimed |
| US-4006218-A | MICROBIOCIDE | JOHNSON & JOHNSON (US) | 1977-02-01 | — | — | US | claimed |
| US-3997705-A | Method of coagulating a fluoro-elastomer from an aqueous dispersion thereof | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1976-12-14 | — | — | US | claimed |
| US-3983209-A | HYDROPHOBIC BIOERODIBLE POLYMER, MICROBIOCIDE OR PROTEOLYTIC ENZYME | ALZA CORPORATION (US) | 1976-09-28 | — | — | US | claimed |
| US-3954630-A | QUATERNARY AMMONIUM CATIONIC SOFTENER, POLYCARBOXYLIC ACID COMPLEXING AGENT | COLGATE-PALMOLIVE COMPANY (US) | 1976-05-04 | — | — | US | claimed |
| US-3944511-A | Chemically modified polymers | OWENS-ILLINOIS, INC. (US) | 1976-03-16 | — | — | US | claimed |